CS logo
small CS logo
Icahn School of Medicine at Mount Sinai

New York, New York, United States
Medical school in New York City, New York
1 Gustave L. Levy Pl, New York, NY 10029

About Icahn School of Medicine at Mount Sinai


The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City. Chartered by Mount Sinai Hospital in 1963, it is the academic teaching arm of The Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Icahn School of Medicine at Mount Sinai


During the past decade, Icahn School of Medicine at Mount Sinai conducted 867 clinical trials. In the 10-year time frame, 867 clinical trials started and 436 clinical trials were completed, i.e. on average, 50.3% percent of trials that started reached the finish line to date. In the past 5 years, 392 clinical trials started and 232 clinical trials were completed. i.e. 59.2% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Icahn School of Medicine at Mount Sinai" #1 sponsor was "Icahn School of Medicine at Mount Sinai" with 374 trials, followed by "Gilead Sciences" with 30 trials sponsored, "Children's Oncology Group" with 29 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 28 trials sponsored and "Bristol-Myers Squibb" with 28 trials sponsored. Other sponsors include 986 different institutions and companies that sponsored additional 520 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Icahn School of Medicine at Mount Sinai" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "Icahn School of Medicine at Mount Sinai" with 57 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 39 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 34 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 29 trials as a collaborator. Other collaborators include 984 different institutions and companies that were collaborators in the rest 461 trials.

Clinical Trials Conditions at Icahn School of Medicine at Mount Sinai


According to Clinical.Site data, the most researched conditions in "Icahn School of Medicine at Mount Sinai" are "Multiple Myeloma" (30 trials), "Breast Cancer" (21 trials), "Prostate Cancer" (20 trials), "Atopic Dermatitis" (19 trials) and "Colorectal Cancer" (19 trials). Many other conditions were trialed in "Icahn School of Medicine at Mount Sinai" in a lesser frequency.

Clinical Trials Intervention Types at Icahn School of Medicine at Mount Sinai


Most popular intervention types in "Icahn School of Medicine at Mount Sinai" are "Drug" (895 trials), "Device" (167 trials), "Other" (145 trials), "Biological" (140 trials) and "Behavioral" (108 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (250 trials), "placebo" (20 trials), "Carboplatin" (16 trials), "Nivolumab" (15 trials) and "Pembrolizumab" (15 trials). Other intervention names were less common.

Clinical Trials Genders at Icahn School of Medicine at Mount Sinai


The vast majority of trials in "Icahn School of Medicine at Mount Sinai" are 1367 trials for "All" genders, 70 trials for "Female" genders and 41 trials for "Male" genders.

Clinical Trials Status at Icahn School of Medicine at Mount Sinai


Currently, there are 414 active trials in "Icahn School of Medicine at Mount Sinai". 6 are not yet recruiting, 268 are recruiting, 129 are Active, not recruiting, and 11 are Enrolling by invitation. In total, there were 851 completed trials in Icahn School of Medicine at Mount Sinai, undefined suspended trials, and 155 terminated clinical trials to date.
Out of the total trials that were conducted in Icahn School of Medicine at Mount Sinai, 206 "Phase 1" clinical trials were conducted, 437 "Phase 2" clinical trials and 293 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 93 trials, and there were also 315 trials that are defined as “Not Applicable".

Departments of Icahn School of Medicine at Mount Sinai


Icahn School of Medicine at Mount Sinai has several departments that took part in Clinical trials: "Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center" - 16 trials, "Icahn School of Medicine at Mount Sinai Beth Israel" - 8 trials, "Icahn School of Medicine at Mount Sinai-Clinical Research Unit" - 4 trials, "Pain and Fatigue Study Center - Beth Israel Medical Center" - 3 trials, "Mount Sinai School of Medicine, Pediatrics" - 2 trials, "Mount Sinai Alzheimer's Disease Research Center" - 2 trials, "Beth Israel Medical Center - AIDS Clinical Trials Unit" - 2 trials, "Icahn School of Medicine at Mount Sinai-Department of Dermatology" - 2 trials, "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" - 2 trials, "Icahn School of Medicine at Mount Sinai, Mount Sinai West" - 2 trials